News
![Sanofi Headquarters in Paris](https://pharmaphorum.com/wp-content/uploads/2018/06/Sanofi1200x675.jpg)
Kymera Therapeutics begins potential $2bn R&D deal with Sano...
US biotech Kymera Therapeutics has begun a strategic collaboration with Sanofi to develop and market several drugs tackling immune-inflammatory disease, which could be worth up to $2 billio